Ardent Health (ARDT) Q2 FY26 earnings call

Ardent Health demonstrated strong operational agility in Q2 FY26, successfully mitigating volume headwinds through increased cost savings and favorable payer contract renegotiations. The company reaffirmed its full-year adjusted EBITDA guidance despite softer volumes, driven by a multi-year "Impact" program and strategic revenue cycle improvements. Management emphasized disciplined execution and accountability to deliver consistent financial results and long-term shareholder value.